Cohort profile: The Nordic Antireflux Surgery Cohort (NordASCo)

Purpose To describe a newly created all-Nordic cohort of patients with gastro-oesophageal reflux disease (GORD), entitled the Nordic Antireflux Surgery Cohort (NordASCo), which will be used to compare participants having undergone antireflux surgery with those who have not regarding risk of cancers,...

Full description

Bibliographic Details
Published in:BMJ Open
Main Authors: Maret-Ouda, John, Wahlin, Karl, Artama, Miia, Brusselaers, Nele, Färkkilä, Martti, Lynge, Elsebeth, Mattsson, Fredrik, Pukkala, Eero, Romundstad, Pål Richard, Tryggvadóttir, Laufey, von Euler-Chelpin, My, Lagergren, Jesper
Format: Article in Journal/Newspaper
Language:English
Published: BMJ Publishing Group 2017
Subjects:
Online Access:http://hdl.handle.net/11250/2558874
https://doi.org/10.1136/bmjopen-2017-016505
id ftntnutrondheimi:oai:ntnuopen.ntnu.no:11250/2558874
record_format openpolar
spelling ftntnutrondheimi:oai:ntnuopen.ntnu.no:11250/2558874 2023-05-15T16:51:56+02:00 Cohort profile: The Nordic Antireflux Surgery Cohort (NordASCo) Maret-Ouda, John Wahlin, Karl Artama, Miia Brusselaers, Nele Färkkilä, Martti Lynge, Elsebeth Mattsson, Fredrik Pukkala, Eero Romundstad, Pål Richard Tryggvadóttir, Laufey von Euler-Chelpin, My Lagergren, Jesper 2017 http://hdl.handle.net/11250/2558874 https://doi.org/10.1136/bmjopen-2017-016505 eng eng BMJ Publishing Group urn:issn:2044-6055 http://hdl.handle.net/11250/2558874 https://doi.org/10.1136/bmjopen-2017-016505 cristin:1539692 Navngivelse-Ikkekommersiell 4.0 Internasjonal http://creativecommons.org/licenses/by-nc/4.0/deed.no CC-BY-NC 7 BMJ Open 6 Journal article Peer reviewed 2017 ftntnutrondheimi https://doi.org/10.1136/bmjopen-2017-016505 2019-09-17T06:54:06Z Purpose To describe a newly created all-Nordic cohort of patients with gastro-oesophageal reflux disease (GORD), entitled the Nordic Antireflux Surgery Cohort (NordASCo), which will be used to compare participants having undergone antireflux surgery with those who have not regarding risk of cancers, other diseases and mortality. Participants Included were individuals with a GORD diagnosis recorded in any of the nationwide patient registries in the Nordic countries (Denmark, Finland, Iceland, Norway and Sweden) in 1964–2014 (with various start and end years in different countries). Data regarding cancer, other diseases and mortality were retrieved from the nationwide registries for cancer, patients and causes of death, respectively. Findings to date The NordASCo includes 945 153 individuals with a diagnosis of GORD. Of these, 48 433 (5.1%) have undergone primary antireflux surgery. Median age at primary antireflux surgery ranged from 47 to 52 years in the different countries. The coding practices of GORD seem to have differed between the Nordic countries. Future plans The NordASCo will initially be used to analyse the risk of developing known or potential GORD-related cancers, that is, tumours of the oesophagus, stomach, larynx, pharynx and lung, and to evaluate the mortality in the short-term and long-term perspectives. Additionally, the cohort will be used to evaluate the risk of non-malignant respiratory conditions that might be caused by aspiration of gastric contents. publishedVersion This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ Article in Journal/Newspaper Iceland NTNU Open Archive (Norwegian University of Science and Technology) Norway BMJ Open 7 6 e016505
institution Open Polar
collection NTNU Open Archive (Norwegian University of Science and Technology)
op_collection_id ftntnutrondheimi
language English
description Purpose To describe a newly created all-Nordic cohort of patients with gastro-oesophageal reflux disease (GORD), entitled the Nordic Antireflux Surgery Cohort (NordASCo), which will be used to compare participants having undergone antireflux surgery with those who have not regarding risk of cancers, other diseases and mortality. Participants Included were individuals with a GORD diagnosis recorded in any of the nationwide patient registries in the Nordic countries (Denmark, Finland, Iceland, Norway and Sweden) in 1964–2014 (with various start and end years in different countries). Data regarding cancer, other diseases and mortality were retrieved from the nationwide registries for cancer, patients and causes of death, respectively. Findings to date The NordASCo includes 945 153 individuals with a diagnosis of GORD. Of these, 48 433 (5.1%) have undergone primary antireflux surgery. Median age at primary antireflux surgery ranged from 47 to 52 years in the different countries. The coding practices of GORD seem to have differed between the Nordic countries. Future plans The NordASCo will initially be used to analyse the risk of developing known or potential GORD-related cancers, that is, tumours of the oesophagus, stomach, larynx, pharynx and lung, and to evaluate the mortality in the short-term and long-term perspectives. Additionally, the cohort will be used to evaluate the risk of non-malignant respiratory conditions that might be caused by aspiration of gastric contents. publishedVersion This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
format Article in Journal/Newspaper
author Maret-Ouda, John
Wahlin, Karl
Artama, Miia
Brusselaers, Nele
Färkkilä, Martti
Lynge, Elsebeth
Mattsson, Fredrik
Pukkala, Eero
Romundstad, Pål Richard
Tryggvadóttir, Laufey
von Euler-Chelpin, My
Lagergren, Jesper
spellingShingle Maret-Ouda, John
Wahlin, Karl
Artama, Miia
Brusselaers, Nele
Färkkilä, Martti
Lynge, Elsebeth
Mattsson, Fredrik
Pukkala, Eero
Romundstad, Pål Richard
Tryggvadóttir, Laufey
von Euler-Chelpin, My
Lagergren, Jesper
Cohort profile: The Nordic Antireflux Surgery Cohort (NordASCo)
author_facet Maret-Ouda, John
Wahlin, Karl
Artama, Miia
Brusselaers, Nele
Färkkilä, Martti
Lynge, Elsebeth
Mattsson, Fredrik
Pukkala, Eero
Romundstad, Pål Richard
Tryggvadóttir, Laufey
von Euler-Chelpin, My
Lagergren, Jesper
author_sort Maret-Ouda, John
title Cohort profile: The Nordic Antireflux Surgery Cohort (NordASCo)
title_short Cohort profile: The Nordic Antireflux Surgery Cohort (NordASCo)
title_full Cohort profile: The Nordic Antireflux Surgery Cohort (NordASCo)
title_fullStr Cohort profile: The Nordic Antireflux Surgery Cohort (NordASCo)
title_full_unstemmed Cohort profile: The Nordic Antireflux Surgery Cohort (NordASCo)
title_sort cohort profile: the nordic antireflux surgery cohort (nordasco)
publisher BMJ Publishing Group
publishDate 2017
url http://hdl.handle.net/11250/2558874
https://doi.org/10.1136/bmjopen-2017-016505
geographic Norway
geographic_facet Norway
genre Iceland
genre_facet Iceland
op_source 7
BMJ Open
6
op_relation urn:issn:2044-6055
http://hdl.handle.net/11250/2558874
https://doi.org/10.1136/bmjopen-2017-016505
cristin:1539692
op_rights Navngivelse-Ikkekommersiell 4.0 Internasjonal
http://creativecommons.org/licenses/by-nc/4.0/deed.no
op_rightsnorm CC-BY-NC
op_doi https://doi.org/10.1136/bmjopen-2017-016505
container_title BMJ Open
container_volume 7
container_issue 6
container_start_page e016505
_version_ 1766042059940036608